Evidence map›Paper›PMID 29668746›Full record

ArticlePloS one2018

Early improvement of executive test performance during antidepressant treatment predicts treatment outcome in patients with Major Depressive Disorder.

Stefanie Wagner, Isabella Helmreich, Daniel Wollschläger, Konstantin Meyer, Sabine Kaaden, Julia Reiff, Sibylle C Roll, Dieter Braus, Oliver Tüscher, Florian Müller-Dahlhaus and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00974155 (Randomised Clinical Trial Comparing Early Medication Change), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00974155 phase4completednot on this map

Randomised Clinical Trial Comparing Early Medication Change (EMC) Strategy With Treatment as Usual (TAU) in Patients With Major Depressive Disorder - the EMC Trial

TypeinterventionalSponsorK. LiebRan2009 to 2014Enrolled889ConditionsDepressionArmsEscitalopram, venlafaxine, lithium, Escitalopram, venlafaxine
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Review
  3. Aberrant functional connectivity associated with drug response in patients with newly diagnosed epilepsy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Stefanie WagnerDepartment of Psychiatry and Psychotherapy, University Medical Centre, Mainz, Germany.ORCID 0000-0002-7013-5109
Isabella HelmreichDepartment of Psychiatry and Psychotherapy, University Medical Centre, Mainz, Germany.
Daniel WollschlägerInstitute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Centre, Mainz, Germany.
Konstantin MeyerSana Klinikum Offenbach, Offenbach, Germany.
Sabine KaadenDepartment of Psychiatry and Psychotherapy, HELIOS Dr. Horst-Schmidt-Kliniken, Wiesbaden, Germany.
Julia ReiffDepartment of Psychiatry and Psychotherapy, HELIOS Dr. Horst-Schmidt-Kliniken, Wiesbaden, Germany.
Sibylle C RollDepartment of Psychiatry and Psychotherapy, Vitos Rheingau, Eltville, Germany.
Dieter BrausDepartment of Psychiatry and Psychotherapy, HELIOS Dr. Horst-Schmidt-Kliniken, Wiesbaden, Germany.
Oliver TüscherDepartment of Psychiatry and Psychotherapy, University Medical Centre, Mainz, Germany.
Florian Müller-DahlhausDepartment of Psychiatry and Psychotherapy, University Medical Centre, Mainz, Germany.
André TadićDepartment of Psychiatry and Psychotherapy, University Medical Centre, Mainz, Germany.
Klaus LiebDepartment of Psychiatry and Psychotherapy, University Medical Centre, Mainz, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Executive dysfunctions frequently occur in patients with Major Depressive Disorder and have been shown to improve during effective antidepressant treatment. However, the time course of improvement and its relationship to treatment outcome is unknown. The aim of the study was to assess the test performance and clinical outcome by repetitive assessments of executive test procedures during antidepressant treatment. Executive test performance was assessed in 209 -patients with Major Depressive Disorder (mean age 39.3 ± 11.4 years) and 84 healthy controls five times in biweekly intervals from baseline to week 8. Patients were treated by a defined treatment algorithm within the early medication change study (EMC trial; ClinicalTrials.gov NCT00974155), controls did not receive any intervention. Cognitive domains were processing speed, cognitive flexibility, phonemic and semantic verbal fluency. Intelligence was assessed at baseline. Depression severity was tested once a week by the Hamilton Depression Rating Scale (HAMD17). 130 patients (62%) showed executive dysfunctions in at least one of four tests at baseline. Linear mixed regression models revealed that the course of depression severity was associated to the course of cognitive flexibility (p = 0.004) and semantic verbal fluency (p = 0.020). Cognitive flexibility and semantic verbal fluency may be candidates easily to apply for therapy response prediction in clinical routine, which should be tested in further prospective studies.

trial registrationClinicalTrials.gov NCT00974155 EudraCT: 2008-008280-96.

Indexed as

AdultAntidepressive AgentsCase-Control StudiesExecutive FunctionFemaleHumansMajor Depressive DisorderMaleMiddle AgedNeuropsychological TestsPsychomotor PerformanceSeverity of Illness IndexTreatment OutcomeAntidepressive Agents

Identifiers

PMID29668746
PMCPMC5905973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.